







ABOUT DATTOLI CANCER CENTER
TREATING PROSTATE CANCER LIKE NO ONE ELSE IN THE WORLD!
1000’s
of SUCCESS STORIES
Best Published Prostate Cancer Cure Rate In The World
LATEST NEWS
- Hypofractionated Radiation Therapy -- A Dark Side
- SRQ Magazine | Top Doctors – Michael J. Dattoli, MD
- Dattoli, M, Kaminski, J., Kaminski, C. Replacing LNT: The Integrated LNT-Hormesis Model – Dose-Response: An International Journal – April – June 2020: 1-3
- Michael J. Dattoli, Joseph M Kaminski, Greg Lawrence, Daniel Kaplon; Risk of urinary morbidity associated with photoselective vaporization of the prostate (PVP) in prostate cancer patients undergoing a combined radiotherapy regimen consisting of dynamic adaptive radiotherapy (DART) and brachytherapy boost. American Society of Clinical Oncology (ASCO), Genitourinary Symposium, February 2021. Reprinted as an Interactive Poster Presentation by the International Journal Hem-Onc, retrieved December, 2021 (https://www.hem-onc.org/poster-05-dattoli).
- Yun, R, Dattoli, M.J., Barentsz, J, Roach, Mack; Radiotherapy (RT) Guided by Ultra-Small Superparamagnetic Iron Oxide (USPIO) - Contrast MRI Staging for Patients With Advanced or Recurrent Prostate Cancer - ASCO-GU 28741, San Francisco - February 2020.
- Dattoli, M, Carnahan, G; Prostate Gland Capsule: Fact or Fiction? DCF Journey Magazine - Fall 2019.
- Solving the Prostate Cancer Puzzle. PAACT Summer 2019.
- Efficacy of Ferumoxytol as a Lymphatic Contrast Agent in Prostate Cancer. ASCO-GU, February 2018.
- Why Focal Therapies Won’t Work. DCF Journey Magazine- Fall 2017.
- Recurrence, what now! Prostate Cancer Communication (PAACT) Volume 33: Number 2- Fall 2017
- Prostate Cancer Comparing Treatment Results Study Group June 2016
- USPIO (Feraheme): Advanced Diagnostics for Prostate Cancer Beyond the Gland
- 3D CFD Ultrasound-Guided, Transperineal Biopsy: The Safest and Most Accurate Prostate Biopsy- February 2015
- Dattoli, M: Active Surveillance: A Dark Side? Prostate Cancer Communication (PAACT) Volume 30: Number 4 – Winter 2014
Dr. Arvind B. Soni
A board-certified Radiation Oncologist, Dr. Soni has a long history of successfully treating prostate cancer and other cancers. Like Dr. Dattoli, Dr. Soni has years of experience performing prostate brachytherapy and advance external radiation therapy (currently DART). He also has a distinguished record of treating breast cancer, including women with tissue expanders and breast implants.
WHAT MAKES THE DATTOLI CANCER CENTER SO SPECIAL?
Drs. Dattoli and Soni have trained at the finest academic cancer research hospitals in the United States and have assembled the largest non-surgical prostate cancer research facility in the world. They have published the highest cure rates with the lowest side effects imaginable and over 50% of patients come to the Dattoli Cancer Center from out-of-state or out of the country after extensively exploring their treatment options.
WE ENCOURAGE GENETIC AND GENOMIC TESTING FOR OUR PATIENTS TO HELP DETERMINE THE BEST TREATMENTS AND MEDICATIONS
At our center, we utilize the Invitae Genetic Cancer Screening Test and the Myriad myRisk® Hereditary Cancer Test. We also use the FoundationOne ® CDx Comprehensive Genomic Profiling Test. These lab tests reveal genetic makeup and often allow us to see which of the patient’s family members are likely to be affected by other cancers. Genomic testing can also help us to identify exactly which treatment and medication may benefit each of our patients.